FdaApplication
NDA 208056
Identifiers
- fda_app_no: NDA208056
Properties
| Property | Value |
|---|---|
| applicant_name | TAKEDA PHARMACEUTICALS USA INC |
| application_type | NDA |
| approval_date | 2016-01-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEXILANT SOLUTAB | DEXLANSOPRAZOLE | 30MG | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL |
1 product